Actos (as pioglitazone hydrochloride) 30 MG Oral Tablet

RxCUI
261267
RxNorm name
Actos (as pioglitazone hydrochloride) 30 MG Oral Tablet
Display name
Actos (as pioglitazone hydrochloride) 30 MG Oral Tablet
Full name
Actos (as pioglitazone hydrochloride) 30 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ActosPIOGLITAZONETakeda Pharmaceuticals America, Inc.d2ddc491-88a9-4063-9150-443b4fa4330c2025-03-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 261267

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
d2ddc491-88a9-4063-9150-443b4fa4330cActos (as pioglitazone hydrochloride) 30 MG Oral TabletSY20These highlights do not include all the information needed to use ACTOS ® safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone) tablets for oral use Initial U.S. Approval: 199920250328
d2ddc491-88a9-4063-9150-443b4fa4330cActos 30 MG Oral TabletPSN20These highlights do not include all the information needed to use ACTOS ® safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone) tablets for oral use Initial U.S. Approval: 199920250328
d2ddc491-88a9-4063-9150-443b4fa4330cActos 30 MG Oral TabletSY20These highlights do not include all the information needed to use ACTOS ® safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone) tablets for oral use Initial U.S. Approval: 199920250328
d2ddc491-88a9-4063-9150-443b4fa4330cpioglitazone 30 MG Oral Tablet [Actos]SBD20These highlights do not include all the information needed to use ACTOS ® safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone) tablets for oral use Initial U.S. Approval: 199920250328
fd156adc-3174-44da-bff7-eeaef5983f18Actos 30 MG Oral TabletSY7ACTOS ® (pioglitazone hydrochloride) Tablets20100901
fd156adc-3174-44da-bff7-eeaef5983f18Actos 30 MG Oral TabletPSN7ACTOS ® (pioglitazone hydrochloride) Tablets20100901
fd156adc-3174-44da-bff7-eeaef5983f18pioglitazone 30 MG Oral Tablet [Actos]SBD7ACTOS ® (pioglitazone hydrochloride) Tablets20100901
fd156adc-3174-44da-bff7-eeaef5983f18Actos (as pioglitazone hydrochloride) 30 MG Oral TabletSY7ACTOS ® (pioglitazone hydrochloride) Tablets20100901
2a97ef74-b338-4655-a60b-923f86720179Actos 30 MG Oral TabletSY3These highlights do not include all the information needed to use ACTOS safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone hydrochloride) tablets for oral use Initial U.S. Approval: 199920120924
2a97ef74-b338-4655-a60b-923f86720179Actos 30 MG Oral TabletPSN3These highlights do not include all the information needed to use ACTOS safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone hydrochloride) tablets for oral use Initial U.S. Approval: 199920120924
2a97ef74-b338-4655-a60b-923f86720179Actos (as pioglitazone hydrochloride) 30 MG Oral TabletSY3These highlights do not include all the information needed to use ACTOS safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone hydrochloride) tablets for oral use Initial U.S. Approval: 199920120924
2a97ef74-b338-4655-a60b-923f86720179pioglitazone 30 MG Oral Tablet [Actos]SBD3These highlights do not include all the information needed to use ACTOS safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone hydrochloride) tablets for oral use Initial U.S. Approval: 199920120924